Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)

Child and Adolescent Psychiatry and Mental Health

Volumn 2, Issue , 2008, Pages

  Wehmeier, Peter M ^a   Schacht, Alexander ^a   Lehmann, Martin ^a   Dittmann, Ralf W ^a,b   Silva, Susan G ^c   March, John S ^c  

^a LILLY DEUTSCHLAND GMBH   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; NEUROLEPTIC AGENT;

ADOLESCENT; AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEHAVIOR THERAPY; CHILD; CHILD HEALTH; CLINICAL ASSESSMENT TOOL; DEPRESSION; DROWSINESS; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMOTIONAL STABILITY; EUPHORIA; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL THERAPY; PARENTAL ATTITUDE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PEDIATRIC ADVERSE EVENT RATING SCALE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PSYCHOTHERAPY; SCORING SYSTEM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 45849152563     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-2-11     Document Type: Article

References (43)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR) Washington, DC: American Psychiatric Association 4 2000.
2. Barkley RA Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder J Clin Psychiatry 2002, (Suppl 12):10-15
3. Biederman J Faraone SV Attention-deficit hyperactivity disorder Lancet 2005, 366:237-248. 10.1016/S0140-6736(05)66915-2 16023516
4. Maedgen JW Carlson CL Social functioning and emotional regulation in the attention deficit hyperactivity disorder subtypes J Clin Child Psychol 2000, 29:30-42. 10.1207/S15374424jccp2901_4 10693030
5. Martel MM Nigg JT Child ADHD and personality/temperament traits of reactive and effortful control, resiliency and emotionality J Child Psychol Psychiatry 2006, 47:1175-1183. 10.1111/j.1469-7610.2006.01629.x 17076757
6. Strine TW Lesesne CA Okoro CA McGuire LC Chapman DP Balluz LS Mokdad AH Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/ hyperactivity disorder Public Health Res Practice and Policy 2006, 3:1-10.
7. Escobar R Soutullo CA Hervas A Gastaminza X Polavieja P Gilaberte I Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children Pediatrics 2005, 116:e364-e369. 10.1542/peds.2005-0386 16140679
8. Harpin VA The effect of ADHD on the life of an individual, their family, and community from preschool to adult life Arch Dis Child 2007, (Suppl 1):i2-i7.
9. Klassen AF Miller A Fine S Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder Pediatrics 2004, 114:e541-e547. 10.1542/peds.2004-0844 15520087
10. Matza LS Rentz AM Secnik K Swensen AR Revicki DA Michelson D Spencer T Newcorn JH Kratochvil CJ The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder J Dev Behav Pediatr 2004, 25:166-174. 10.1097/ 00004703-200406000-00005 15194901
11. Riley AW Spiel G Coghill D Döpfner M Falissard B Lorenzo MJ Preuss U Ralston SJ ADORE Study Group Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment Eur Child Adolesc Psychiatry 2006, (Suppl 1):i38-i45. 10.1007/ s00787-006-1006-9
12. Sawyer MG Whaites L Rey JM Hazell PL Graetz BW Baghurst P Health-related quality of life of children and adolescents with mental disorders J Am Acad Child Adolesc Psychiatry 2002, 41:530-537. 10.1097/ 00004583-200205000-00010 12014785
13. Jensen PS Hinshaw SP Swanson JM Greenhill LL Conners CK Arnold LE Abikoff HB Elliott G Hechtman L Hoza B March JS Newcorn JH Severe JB Vitiello B Wells K Wigal T Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers J Dev Behav Pediatr 2001, 22(1):60-73. 11265923
14. Banaschewski T Roessner V Dittmann RW Santosh PJ Rothenberger A Non-stimulant medications in the treatment of ADHD Eur Child Adolesc Psychiatry 2004, (Suppl 1):102-116.
15. Becker K Wehmeier PM Schmidt MH The Noradrenergic Transmitter System in ADHD: Principles and Implications for Treatment Stuttgart: Thieme 2006.
16. Michelson D Allen AJ Busner J Casat C Dunn D Kratochvil C Newcorn J Sallee FR Sangal RB Saylor K West S Kelsey D Wernicke J Trapp NJ Harder D Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study Am J Psychiatry 2002, 159:1896-1901. 10.1176/ appi.ajp.159.11.1896 12411225
17. Michelson D Faries D Wernicke J Kelsey D Kendrick K Sallee R Spencer T Atomoxetine ADHD Study Group Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study Pediatrics 2001, 108:AE83-e91. 10.1542/peds.108.5.e83
18. Kelsey DK Sumner CR Casat CD Coury DL Quintana H Saylor KE Sutton VK Gonzales J Malcolm SK Schuh KJ Allen AJ Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial Pediatrics 2004, 114:e1-e8. 10.1542/ peds.114.1.e1 15231966
19. Spencer T Heiligenstein JH Biederman J Faries DE Kratochvil CJ Conners CK Potter WZ Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder J Clin Psychiatry 2002, 63:1140-1147. 12523874
20. Cheng JYW Chen RYL Ko JSN Ng EML Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents. Meta-analysis and meta-regression analysis Psychopharmacology 2007, 194(2):197-209. published online, DOI 10.1007/s00213-007-0840-x 10.1007/ s00213-007-0840-x 17572882
21. DuPaul GJ Power TJ Anastopoulos AD Reid R ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations New York: Guilford 1998.
22. Faries DE Yalcin I Harder D Heiligenstein JH Validation of the ADHD Rating Scale as a clinician administered and scored instrument J Atten Disord 2001, 5:39-47. 10.1177/108705470100500204
23. Guy W ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338 Washington, DC: US Department of Health, Education and Welfare 1976:218-222.
24. National Institutes of Mental Health (NIMH) Psychopharmacology Bulletin 1985, 21:839-943.
25. Landgraf J Abetz L Ware J Child Health Questionnaire (CHQ): A Users Manual Boston: Integrated Therapeutics Group 1996.
26. Riley AW Robertson J Forrest CB Green B Rebok G Starfield B Manual for the Child Health and Illness Profile-Child Edition (CHIP-CETM) Baltimore, MD: The Johns Hopkins University 2001.
27. Klassen AF Miller A Fine S Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder Child Care Health Dev 2006, 32:397-406. 10.1111/ j.1365-2214.2006.00609.x 16784495
28. Dittmann RW Wehmeier PM Lehmann M Schacht A Helsberg K Lehmkuhl G Behandlung von ADHS bei Jugendlichen in Deutschland: Offene Studie zur Effektivität und Verträglichkeit von Atomoxetin aus Sicht von Arzt, Eltern und Patient Nervenarzt 2006, (suppl 3):S300.
29. Wehmeier PM Dittmann RW Schacht A Minarzyk A Lehmann M Sevecke K Lehmkuhl G Effectiveness of atomoxetine in children with attention-deficit/hyperactivity disorder and quality of life as perceived by patients, parents and physicians in an open-label study J Child Adolesc Psychopharmacol 2007, 17:813-829. 10.1089/cap.2007.0025 18315453
30. March J Karayal O Chrisman A CAPTN: The Pediatric Adverse Event Rating Scale The Scientific Proceedings of the 2007 Annual Meeting of the American Academy of Child and Adolescent Psychiatr: 23-28 October 2007; Boston Novins DK, DeYoung 2007:241.
31. Vitiello B Research in child and adolescent psychopharmacology: Recent accomplishments and new challenges Psychopharmacology 2007, 191:5-13. 10.1007/s00213-006-0414-3 16718480
32. Greenhill LL Vitiello B Abikoff H Levine J March JS Riddle MA Capasso L Cooper TB Davies M Fisher P Findling RL Fried J Labellarte MJ McCracken JT McMahon D Robinson J Skrobala A Scahill L Veripatis E Walkup JT Zito JM Developing methodologies for monitoring long-term safety of psychotropic medications in children: Report on the NIMH conference, September 25, 2000 J Am Acad Child Adolesc Psychiatry 2003, 42:651-655. 10.1097/01.CHI.0000046842.56865.EC 12921472
33. Greenhill LL Vitiello B Fisher P Levine J Davies M Abikoff H Chrisman AK Chuang S Findling RL March J Scahill L Walkup J Riddle MA Comparison of increasingly detailed eliciation methods for the assessment of adverse events in pediatric psychopharmacology J Am Acad Child Adolesc Psychiatry 2004, 43:1488-1496. 10.1097/01.chi.0000142668.29191.13 15564818
34. March J Silva SG Compton S Anthony G DeVeaugh-Geiss J Califf R Krishnan R The Child and Adolescent Psychiatry Trials Network (CAPTN) J Am Acad Child Adolesc Psychiatry 2004, 43:515-518. 10.1097/ 00004583-200405000-00004 15100557
35. Döpfner M Lehmkuhl G DISYPS-JK: Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV Bern: Verlag Hans Huber 2000.
36. Thomason C Michelson D Atomoxetine: Treatment of attention deficit hyperactivity disorder: Beyond stimulants Drugs of Today 2004, 40:465-473. 10.1358/dot.2004.40.5.850493 15319800
37. Concato J Shah N Horwitz RI Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 2000, 342:1887-1892. 1557642 10861325 10.1056/NEJM200006223422507
38. Berger A Kofman O Livneh U Henik A Multidisciplinary perspectives on attention and the development of self-regulation Progress in Neurobiology 2007, 82:256-286. 10.1016/j.pneurobio.2007.06.004 17651888
39. Ochsner KN Gross JJ The cognitive control of emotion Trends in Cogn Sciences 2005, 9:242-249. 10.1016/j.tics.2005.03.010
40. Hinshaw SP Impulsivity, emotion regulation, and developmental psychopathology: Specificity versus generality of linkages Ann NY Acad Sci 2003, 1008:I149-159. 10.1196/annals.1301.016
41. Klimkeit I Graham C Lee P Morling M Russo D Tonge B Children should be seen and heard. Self-report of feelings and behavior in primary-school-age children with ADHD Journal of Attention Disorders 2006, 10:181-191. 10.1177/1087054706289926 17085628
42. Kratochvil CJ Faries D Vaughan B Perwien A Busner J Saylor K Kaplan S Buermeyer C Swindle R Emotional expression during Attention-Deficit/ Hyperactivity Disorders treatment: Initial assessment of treatment effects J Child Adolesc Psychopharm 2007, 17(1):51-62. 10.1089/ cap.2006.0018
43. Reimherr FW Marchant BK Strong RE Hedges DW Adler L Spencer TJ West SA Soni P Emotional dysregulation in adult ADHD and response to atomoxetine Biol Psychiatry 2005, 58:125-131. 10.1016/j.biopsych.2005.04.040 16038683